COEP Coeptis Therapeutics
- 0.273
- -0.004-1.27%
Coeptis Therapeutics News
10-Q: Quarterly report
Coeptis Therapeutics | 10-K: Annual report
Coeptis Therapeutics | 424B3: Prospectus
Coeptis Therapeutics | 424B3: Prospectus
Coeptis Therapeutics | 10-Q/A: Quarterly report (Amendment)
Coeptis Therapeutics | 10-Q/A: Quarterly report (Amendment)
Coeptis Therapeutics | 10-Q/A: Quarterly report (Amendment)
Coeptis Therapeutics | 10-K/A: Annual report (Amendment)
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.96%),Steven Boyd(9.96%)
Coeptis Therapeutics | 424B3: Prospectus
Coeptis Therapeutics | 424B3: Prospectus
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cogley Brian
Coeptis Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Cogley Brian
Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DeSilva Tara
Coeptis Therapeutics | SCHEDULE 13G: Others
Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yerace Daniel Alexander
Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Salkind Gene
Coeptis Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mehalick David
Analysis
Price Target
No Data
